Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

1 of 0 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 2
1(33.3%)
3Total
N/A(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03945968Recruiting

The Role of Concomitant Diseases in Postoperative Complications Risk Stratification.

Role: collaborator

NCT06146270Recruiting

Russian Registry of Surgical OutcomeS

Role: collaborator

NCT06066931Not ApplicableNot Yet Recruiting

Reconstruction of the Pelvic Floor and Perineal Wound After Rectal ELAPE

Role: lead

NCT05143723Phase 2Unknown

Luteal Phase Support With Daily Administration of Gonadotropin-releasing Hormone Agonist Compared to Progesterone/Estradiol in IVF/ICSI Cycles With Ovulation Triggering With GnRH-a

Role: lead

NCT01997437Not ApplicableUnknown

Laryngo-Tracheal Tissue-Engineered Clinical Transplantation

Role: lead

All 5 trials loaded